A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002

被引:3
作者
Aquilina, S. [1 ]
Dalmas, M.
Calleja, N.
Gatt, P.
Scerri, L.
机构
[1] Univ Malta, Sch Med, Sir Paul Boffa Hosp, Dept Dermatol, Floriana VLT 12, Malta
[2] Malta Natl Canc Registry, Dept Hlth Informat, Guardamangia MSD 08, Malta
关键词
cutaneous malignant melanoma; incidence; survival;
D O I
10.1111/j.1468-3083.2006.01694.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background The incidence of malignant melanoma of the skin has risen in every part of the world where reliable cancer registration data are found. Objective Our study aims to describe the changing incidence of and survival from invasive cutaneous malignant melanoma in Malta, by analysing the data from the 211 cases that were registered at the Malta National Cancer Registry between 1993 and 2002. Results The age standardized incidence rates for invasive cutaneous malignant melanoma rose from 3.7 per 100 000 population per year for males and 5.1 for females in the first 5-year period, to 8.0 per 100 000 population per year for males and 5.9 for females in the second 5-year period. In both sexes, numbers of thin (<= 1.0 mm) invasive melanomas increased significantly between 1993 and 2002; males also registered a significant increase in intermediate-thickness (1.01-4.0 mm) melanomas. The increase in numbers of thin and intermediate-thickness melanomas between the two 5-year periods was greatest in patients aged 60 years and over. The overall absolute 5-year survival rate for the first period was 74% and for the second period 92%. Conclusion Numbers of reported cases of invasive cutaneous malignant melanoma in Malta have more than doubled during the 10-year study period. This is mostly due to a marked rise in the diagnosis of thin melanomas in both sexes, occurring mainly in patients aged 60 years and over. As thin melanomas are of low metastasizing potential, this has resulted in an increase in survival between the two 5-year study periods.
引用
收藏
页码:958 / 963
页数:6
相关论文
共 19 条
[1]  
Armstrong B. K., 1996, CANC EPIDEMIOLOGY PR, V2nd, P1282
[2]  
Autier P, 1998, INT J CANCER, V77, P533, DOI 10.1002/(SICI)1097-0215(19980812)77:4<533::AID-IJC10>3.0.CO
[3]  
2-7
[4]   Melanoma incidence trends [J].
Bevona, C ;
Sober, AJ .
DERMATOLOGIC CLINICS, 2002, 20 (04) :589-+
[5]   RECENT INCIDENCE TRENDS IMPLY A NONMETASTASIZING FORM OF INVASIVE MELANOMA [J].
BURTON, RC ;
ARMSTRONG, BK .
MELANOMA RESEARCH, 1994, 4 (02) :107-113
[6]   Cutaneous malignant melanoma in Europe [J].
de Vries, E ;
Coebergh, JW .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (16) :2355-2366
[7]   Analysis of the melanoma epidemic, both apparent and real - Data from the 1973 through 1994 surveillance, epidemiology, and end results program registry [J].
Dennis, LK .
ARCHIVES OF DERMATOLOGY, 1999, 135 (03) :275-280
[8]   Update on the incidence and mortality from melanoma in the United States [J].
Hall, HI ;
Miller, DR ;
Rogers, JD ;
Bewerse, B .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (01) :35-42
[9]  
MacKie RM, 1997, BRIT MED J, V315, P1117, DOI 10.1136/bmj.315.7116.1117
[10]   Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98) [J].
McMullen, EA ;
Kee, F ;
Patterson, CC ;
Gavin, AT ;
Dolan, OM .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (03) :587-593